3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3 Purity ≥99.0% (HPLC) Favipiravir Intermediate COVID-19

Incazelo emfushane:

Igama Lekhemikhali: 3,6-Difluoropyrazine-2-Carbonitrile

I-CAS: 356783-28-3

Ukubukeka: Okuphuzi Okuphaphathekile kuya Kuphuphu Olumhlophe

Ubumsulwa: ≥99.0% (HPLC)

I-Intermediate ye-Favipiravir (CAS 259793-96-9) ekwelapheni Ukutheleleka Ngegciwane Lomkhuhlane kanye ne-COVID-19

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

Inquiry: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

I-Favipiravir yezohwebo kanye Nezixhumanisi Ezihlobene:
I-Favipiravir CAS 259793-96-9
I-2-Aminopropanediamide CAS 62009-47-6
I-Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
I-3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
I-6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
I-6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Chemical Properties:

Igama Lekhemikhali	3,6-Difluoropyrazine-2-Carbonitrile
Inombolo ye-CAS	356783-28-3
Inombolo yeCAT	I-RF-PI227
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula	I-C5HF2N3
Isisindo samangqamuzana	141.08
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	Impushana Ephuzi Okuphaphathekile ukuya kokumhlophe
Ubumsulwa	≥99.0%
Ukulahlekelwa Ekumisweni	≤1.0%
Izinsalela ekushiseni	≤0.50%
Ukungcola Okukodwa	≤0.50%
Ukungcola Okuphelele	≤1.0%
Izinsimbi Ezisindayo	≤20ppm
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	I-Favipiravir emaphakathi (CAS: 259793-96-9)

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.

Izinzuzo:

I-FAQ:

Isicelo:

I-3,6-Difluoropyrazine-2-Carbonitrile (CAS: 356783-28-3) iphakathi kwe-Favipiravir (CAS: 259793-96-9).I-Favipiravir yagunyazwa ukumakethwa e-Japan ngo-March 2014 futhi yasetshenziselwa ukwelashwa kwe-antiviral yomkhuhlane A no-B. Ngaphezu kwegciwane lomkhuhlane, umuthi ubuye wabonisa umsebenzi omuhle wokulwa namagciwane ezinhlobonhlobo zamagciwane e-RNA, njengegciwane le-Ebola, igciwane lesihlabathi, Igciwane le-Bunia, igciwane lamarabi, njll. I-Novel coronavirus pneumonia ivinjelwa ucwaningo lwakamuva.